Recurrent Breast Cancer Clinical Trials

139 clinical trials for Recurrent Breast Cancer across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer — RECRUITING · PHASE2
• PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer — RECRUITING · PHASE1
• Bortezomib Plus Cisplatin in Recurrent or Metastatic Breast Cancer — RECRUITING · PHASE1
• A Study of Diffusing Alpha Radiation Therapy for Patients With Breast Carcinoma in Frail or Elderly Patients. — RECRUITING · NA
• A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast Cancer — RECRUITING · PHASE1
• Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer — COMPLETED · PHASE2
• Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery — ACTIVE_NOT_RECRUITING · PHASE3
• ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast Cancer — COMPLETED · PHASE1
• Phase Ib Dose-escalation Trial of Taselisib (GDC-0032) in Combination With Anti-HER2 Therapies in Participants With Advanced HER2+ Breast Cancer — COMPLETED · PHASE1
• Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer — ACTIVE_NOT_RECRUITING · NA
• Circulating miRNAs. — COMPLETED
• A Study to Investigate LYL797 in Adults With Solid Tumors — TERMINATED · PHASE1
• A Biomarker Screening Protocol for Participants With Solid Tumors — TERMINATED
• Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation Therapy — COMPLETED · NA
• A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS) — ACTIVE_NOT_RECRUITING · NA
• Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer — TERMINATED · PHASE1
• Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III Breast Cancer — COMPLETED · PHASE2
• T-DM1 and Palbociclib for Metastatic HER2 Breast Cancer — COMPLETED · PHASE2
• Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer — COMPLETED
• BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer — OTHER · PHASE1
• Reoperative Sentinel Lymph Node Biopsy in Patients With Recurrent Ipsilateral Breast Cancer — OTHER
• Sorafenib in Treating Patients With Metastatic Breast Cancer — COMPLETED · PHASE2
• Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting — COMPLETED · PHASE2
• Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer — COMPLETED · PHASE2
• Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast Cancer — TERMINATED · PHASE2
• PET/CT in Evaluating Response to Chemotherapy in Patients With Breast Cancer — TERMINATED · NA
• A Study of Foretinib in Patients With Recurrent/Metastatic Breast Cancer — COMPLETED · PHASE2
• Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene — COMPLETED · PHASE1
• B002 in Patients With HER2-positive Breast Cancer — COMPLETED · PHASE1
• Omega-3 Fatty Acids in Preventing Joint Symptoms in Patients With Stage I-III Breast Cancer Receiving Anastrozole, Exemestane, or Letrozole — COMPLETED · NA
• Phase II Study of Everolimus Beyond Progression — TERMINATED · PHASE2
• Toll-like Receptor (TLR) 7 Agonist, Cyclophosphamide, and Radiotherapy for Breast Cancer With Skin Metastases — COMPLETED · PHASE1
• Comprehensive Gene Sequencing in Guiding Treatment Recommendations Patients With Metastatic or Recurrent Solid Tumors — COMPLETED
• ModraDoc006/r in Patients With Breast Cancer — COMPLETED · PHASE2
• Ruxolitinib W/ Preop Chemo For Triple Negative Inflammatory Brca — COMPLETED · PHASE1
• Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer — COMPLETED · PHASE2
• Abbreviated Breast MRI for Second Breast Cancer Detection in Women With BRCA Mutation Testing — OTHER
• Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metastatic or Locally Recurrent Breast Cancer That Cannot be Removed by Surgery Receiving Everolimus — COMPLETED · PHASE2
• Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection — TERMINATED · PHASE1
• 2nd Line Treatment With Pemetrexed and Sorafenib for Recurrent or Metastatic Triple Negative Breast Cancer — TERMINATED · PHASE2
• BYL719 + T-DM1 in HER2(+) Metastatic Breast Cancer Pts Who Progress on Prior Trastuzumab & Taxane Tx — COMPLETED · PHASE1
• Acupuncture in Treating Women With Stage I, Stage II, or Stage III Breast Cancer With Aromatase Inhibitor-Related Joint Pain — COMPLETED · NA
• F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast Cancer — COMPLETED · PHASE2
• Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer — COMPLETED · PHASE1
• Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy — COMPLETED · NA
• Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer With CNS Metastasis — COMPLETED · PHASE1
• Ixabepilone and Vorinostat in Treating Patients With Metastatic Breast Cancer — COMPLETED · PHASE1
• Cabergoline in Metastatic Breast Cancer — COMPLETED · PHASE1
• Combination of Trastuzumab and NK Immunotherapy for Recurrent Breast Cancer — COMPLETED · PHASE1
• Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy — COMPLETED · NA

Refine this search